Re: debenture
in response to
by
posted on
Mar 20, 2023 12:05PM
Wow. Koo you nailed it.
A clue, perhaps?
"Over the past several months we have been working diligently with Hepalink in order to prepare for their involvement in our upcoming BETonMACE2 trial which has FDA Breakthrough Therapy Designation"